Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
12/2008
12/11/2008WO2008150577A1 Vaccine for the prevention of breast cancer relapse
12/11/2008US20080305542 G protein coupled receptor (GPCR) polypeptide, attached to a detectable label seleacted from green fluorescent polypeptide or a rhodopsin polypeptide, involved in bitter taste transduction; used as additives for foods, beverages and drugs in order to modify T2R-associated bitter taste
12/11/2008US20080305101 Methods and Compositions Related to Clot Binding Compounds
12/11/2008US20080305037 Linkers for anchoring targeting ligands
12/11/2008CA2687368A1 Vaccine for the prevention of breast cancer relapse
12/10/2008EP0804595B1 Resorbable synthetic proteins as implantables
12/09/2008US7462692 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides
12/09/2008US7462689 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
12/09/2008US7462486 Monitoring the efficacy of a T Cell Receptor (TCR) Variable peptide for the treatment of autoimmune diseases such as multiple sclerosis, Rheumatoid arthritis, systemic lupus erythematosis, type I diabetes, non-obese diabetes, psoriasis
12/09/2008US7462462 Peptide capable of binding to nanographite structures
12/09/2008US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
12/09/2008US7462352 Methods of treatng B-cell diseases using humanized anti-CD19 antibodies
12/04/2008WO2008148063A1 Intranuclear protein transduction through a nucleoside salvage pathway
12/04/2008WO2008146906A1 Porous carrier having formyl group, absorbent using the porous carrier, method for production of the porous carrier, and method for production of the absorbent
12/04/2008WO2008146707A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof
12/04/2008WO2007149982A3 Diagnosis of autoimmune disease
12/04/2008WO2007146261A3 Biomolecule-linked biomimetic scaffolds
12/04/2008WO2007117588A3 Soluble virus-specific t-cell receptor compositions
12/04/2008WO2007114959A3 Altered peptide ligands of gad65
12/04/2008US20080299678 Methods for characterizing glycosylation sites
12/04/2008US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors
12/04/2008CA2688240A1 Intranuclear protein transduction through a nucleoside salvage pathway
12/04/2008CA2687908A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof
12/04/2008CA2687887A1 Self-assembled proteins and related methods and protein structures
12/03/2008CN100439391C Process for producing hydrophobic polypeptides, proteins or peptides
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459533 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders
12/02/2008US7459291 Chordin-like molecules and uses thereof
12/02/2008US7459275 Sequencing of surface immobilized polymers utilizing microfluorescence detection
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
11/2008
11/27/2008WO2008143731A2 Surface grafted conjugated polymers
11/27/2008WO2008103966A3 Compositions and methods using toll-like receptors and unc93b
11/27/2008WO2008103947A3 Activation of human antigen-presenting cells through clec-6
11/27/2008WO2008039483A3 Modified self-assembling peptides
11/27/2008WO2007120728A3 Mathematical design of ion channel selectivity via inverse problems technology
11/27/2008US20080293118 Magnetic fine particles having lower critical solution temperature
11/27/2008US20080292628 Chimeric Protein
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/20/2008WO2008141274A1 Anti-alpha v immunoliposome composition, methods and uses
11/20/2008WO2008097854A3 Method and substances for treating hpv infection
11/20/2008WO2007075414A3 Chemically derivatized cd4 and uses thereof
11/20/2008US20080286228 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/20/2008CA2668100A1 Compositions and methods for immunodominant antigens
11/19/2008EP1992692A1 Immunoglobulin affinity ligand
11/19/2008EP1991273A2 Labeling and detection of post translationally modified proteins
11/19/2008CN101306352A Large particle diameter mono-disperse polymer microspheres containing epoxy group and preparation method thereof
11/18/2008US7452982 An immunogenic complex characterised in that an enzyme is integrated into an immunostimulating complex (ISCOM) containing a glycoside, a lipid and an antigen
11/18/2008US7452858 Administering exendin, or an antagonist thereof; reducing blood glucose concentration
11/18/2008US7452856 partial peptide based upon the amino acid sequences of a guinea-pig-derived antimicrobial polypeptide and partially substituted forms; lipopolysaccharide-cell-binding inhibitor
11/18/2008US7452681 identifying markers indicative of the risk of developing a neurodevelopmental disorder caused in part by antibody- or autoantibody-mediated damage of neural tissue
11/18/2008US7452679 Hybridization; phage display; spectroscopy
11/18/2008CA2210491C Antagonists of interleukin-15
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/16/2008CA2684215A1 Delivery of micro- and nanoparticles with blood platelets
11/13/2008WO2008022349A3 Agents for blood-brain barrier delivery
11/13/2008WO2007133835A3 Ras mutation and compositions and methods related thereto
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008CA2685592A1 Pp1 ligands
11/12/2008EP1432729B1 Peyers's patch and/or m-cell targeting ligands
11/12/2008EP1421387B1 Cellular immunity test with peptides fixed on a solid support
11/12/2008CN100432106C Method for conserving antiseptic peptide using attachment method
11/11/2008US7449560 Phosophoinositoglycan binding proteins
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449554 Antibodies against the PRO4977 polypeptides
11/11/2008US7449549 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
11/11/2008US7449445 Conductive peptide nanofiber and method of manufacture of the same
11/11/2008US7449187 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease
11/06/2008WO2008134731A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
11/06/2008WO2008133433A2 Intact surface display of substances of interest
11/06/2008WO2008133164A1 Immobilized protein immobilized only at its amino terminal in orientation-controlled manner
11/06/2008WO2008073174A3 Antimicrobial therapy
11/06/2008WO2008036337A3 Predicted phosphorylation sites
11/06/2008WO2008030429A3 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators
11/06/2008WO2008019305A3 Improved synthesis of labeled probes
11/06/2008WO2007100580A3 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
11/06/2008CA2685350A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
11/05/2008EP1987068A1 Oligosaccharide modification and labeling of proteins
11/05/2008EP1789452A4 Relaxin-chimeric polypeptides and their preparation and use
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/04/2008US7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
11/04/2008US7446174 Protein based TNF-α variants for the treatment of TNF-α related disorders
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
10/2008
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008109533A3 Human antibodies that bind multiple irta family proteins, and uses thereof
10/30/2008WO2008098139A3 Axl tyrosine kinase inhibitors and methods of making and using the same
10/30/2008WO2008057709A3 Sol-gel materials for cellular modulation
10/30/2008WO2008024311A3 Purification of low-abundant recombinant proteins from cell culture
10/30/2008US20080269074 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation
10/30/2008CA2690772A1 Novel peptide amphiphiles having improved solubility and methods of using same
10/29/2008CN101296945A Immunogenic compositions and methods of use
10/28/2008US7442777 Cytotoxicity mediation of cells evidencing surface expression of CD63
10/28/2008US7442681 regulating vascular permeability. A peptide inhibitor of p21-activated kinase has been found to inhibit the increase in vascular permeability induced by several factors. The present invention further provides methods of identifying regulators of vascular permeability.
10/28/2008US7442513 Method of screening for agents that modulate a homer signaling pathway
10/23/2008WO2008043102A8 Vasoactive intestinal polypeptide compositions
10/23/2008WO2006121926A8 Neural regeneration peptides and methods for their use
10/23/2008US20080262087 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners
10/23/2008US20080261327 Cell Free Assay for Determining a Substance of Interest and Molecular Complexes Used Therefore
10/23/2008US20080260773 Carrier protein containing t cell epitopes from pathogens conjugated to saccharide antigens
10/22/2008EP0833941B1 Polypeptides having a functional domain of interest and methods of identifying and using same
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 107